Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya

Journal of Clinical Microbiology

Volumn 38, Issue 7, 2000, Pages 2688-2695

  Emery, Sandra ^a   Bodrug, Sharon ^b   Richardson, Barbra A ^a   Giachetti, Cristina ^b   Bott, Martha A ^b   Panteleeff, Dana ^a   Jagodzinski, Linda L ^c   Michael, Nelson L ^d   Nduati, Ruth ^e   Bwayo, Job ^e   Kreiss, Joan K ^a   Overbaugh, Julie ^a,f  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Gen Probe Incorporated   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE AMPLIFICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; KENYA; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; VIRUS DIAGNOSIS; VIRUS ISOLATION; VIRUS TYPING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033929541     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.7.2688-2695.2000     Document Type: Article

References (41)

1. Alaeus, A., K. Lidman, A. Sonnerborg, and J. Albert. 1997. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 11:859-865.
2. Berger, A., J. Braner, H. W. Doerr, and B. Weber. 1998. Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Intervirology 41:24-34.
3. Bodrug, S., R. Domingo, J. Holloway, M. Sanders, K. Nunomura, C. Sloan, and B. Billyard. 1997. Gen-Probe single tube quantitative HIV assay. J. Clin. Microbiol. Infect. 3:1050.
4. Brodine, S. K., J. R. Mascola, P. J. Weiss, S. I. Ito, K. R. Porter, A. W. Artenstein, F. C. Garland, F. E. McCutchan, and D. S. Burke. 1995. Detection of diverse HlV-1 genetic subtypes in the USA. Lancet 346:1198-1199.
5. Brodine, S. K., R. A. Shaffer, M. J. Starkey, S. A. Tasker, J. L. Gilcrest, M. K. Louder, A. Barile, T. C. VanCott, M. T. Vahey, F. E. McCutchan, D. L. Birx, D. D. Richman, and J. R. Mascola. 1999. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann. Intern. Med. 131:502-506.
6. Burke, D. S., and F. E. McCutchan. 1997. Global distribution of human immunodeficiency virus-1 clades, p. 119-126. In T. DeVita, Jr., S. H. Vincent, and S. A. Rosenberg (ed.), AIDS: biology, diagnosis, treatment and prevention. 4th ed. Lippincott-Raven, Philadelphia, Pa.
7. Coste, J., B. Montes, J. Reynes, M. Peeters, C. Segarra, J. P. Vendrell, E. Delaporte, and M. Segondy. 1996. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 50:293-302.
8. de Baar, M., A. van der Schoot, J. Goudsmit, F. Jacobs, R. Ehren, K. van der Horn, P. Oudshoorn, F. de Wolf, and A. de Ronde. 1999. Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target. J Clin Microbiol. 37:1813-1818.
9. Dunne, A. L., and S. M. Crowe. 1997. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma. AIDS 11:126-127.
10. Giachetti, C., D. Kolk, J. Dockter, J. Knowlton, R. Wang, H. Hotaling, and S. McDonough. 1998. High throughput assay for sensitive detection of HIV-1 RNA of diverse origins, including type O strains, p. 151-155. In The 12th World AIDS Conference. Monduzzi Editore S. p. A., Bologna, Italy.
11. Gobbers, E., K. Fransen, T. Oosterlaken, W. Janssens, L. Heyndrickx, T. Ivens, K. Vereecken, R. Schoones, P. van de Wiel, and G. van der Groen. 1997. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J. Virol. Methods. 66:293-301.
12. Hoff, R., and L. K. Barker. 1995. Trial objectives and end points for measuring the efficacy of HIV vaccines. Infect. Agents Dis. 4:95-101.
13. Holguin, A., C. de Mendoza, and V. Soriano. 1999. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes. Eur. J Clin. Microbiol. Infect. Dis. 18: 256-259.
14. Hu, D. J., T. J. Dondero, M. A. Rayfield, J. R. George, G. Schochetman, H. W. Jaffe, C. C. Luo, M. L. Kalish, B. G. Weniger, C. P. Pau, C. A. Schable, and J. W. Curran. 1996. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA 275:210-216.
15. Irwin, K. L., C. P. Pau, D. Lupo, D. Pienazek, C. C. Luo, N. Olivo, M. Rayfield, D. J. Hu, J. T. Weber, R. A. Respess, R. Janssen, P. Minor, and J. Ernst. 1997. Presence of human immunodeficiency virus (HIV) type 1 subtype A infection in a New York community with high HIV prevalence: a sentinel sile for monitoring HIV genetic diversity in North America. J. Infect. Dis. 176:1629-1633.
16. Janssens, W., A. Buve, and J. N. Nkengasong. 1997. The puzzle of HIV-1 subtypes in Africa. AIDS 11:705-712.
17. Kacian, D. L., and T. J. Fultz. 1995. Nucleic acid sequence amplification methods. U.S. patent 5,399,491.
18. Katzenstein, D. A., S. M. Hammer, M. D. Hughes, H. Gundacker, J. B. Jackson, S. Fiscus, S. Rasheed, T. Elbeik, R. Reichman, R. Japour, T. C. Merigan, and M. S. Hirsch. 1996. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N. Engl. J. Med. 335: 1091-1098.
19. Kern, D., M. Collins, T. Fultz, J. Detmer, S. Hamren, J. J. Peterkin, P. Sheridan, M. Urdea, R. White, T. Yeghiazarian, and J. Todd. 1996. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:3196-3202.
20. Leitner, T., D. Escanilla, S. Marquina, J. Wahlberg, C. Brostrom, H. B. Hansson, M. Uhlen, and J. Albert. 1995. Biological and molecular characterization of subtype D, G and A/D recombinant HIV-1 transmission in Sweden. Virology 209:136-145.
21. Lewis, P., R. Nduati, J. K. Kreiss, G. C. John, B. Richardson, D. Mbori-Ngacha, J. Ndinya-Achola, and J. Overbaugh. 1998. Cell-free HIV-1 in breast milk. J. Infect. Dis. 177:34-39.
22. Louwagie, J., W. Janssens, J. Mascola, L. Heyndrickx, P. Hegerich, G. van der Groen, F. E. McCutchan, and D. S. Burke. 1995. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69:263-271.
23. Louwagie, J., F. E. McCutchan, M. Peeters, T. P. Brennan, E. Sanders-Buell, G. A. Eddy, G. van-der-Groen, K. Fransen, G. M. Gershy-Damet, R. Deleys, and D. S. Burke. 1993. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 7: 769-780.
24. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, Jr., J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
25. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
26. Michael, N. L., S. A. Herman, S. Kwok, K. Dreyer, J. Wang, C. Christopherson, J. P. Spadoro, K. K. Young, V. Polonis, F. E. McCutchan, J. Carr, J. R. Mascola, L. L. Jagodzinski, and M. L. Robb. 1999. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J. Clin. Microbiol. 37: 2557-2563.
27. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
28. Myers, G., B. Korber, J. A. Berzofsky, R. F. Smith, and G. N. Pavlakis. 1997. Human retroviruses and AIDS. Theoretical Biology and Biophysics Group T-10, Los Alamos National Laboratory, Los Alamos, N.Mex.
29. Nduati, R. W., G. John, D. Mbori-Ngacha, B. A. Richardson, J. Overbaugh, A. Mwatha, J. O. Ndinya-Achola, J. Bwayo, F. E. Onyango, J. Hughes, and J. K. Kreiss. 2000. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283:1167-1174.
30. Neilson, J., G. John, J. K. Carr, P. Lewis, J. K. Kreiss, S. Jackson, R. W. Nduati, D. Mbori-Ngacha, D. Panteleeff, S. Bodrug, C. Giachetti, M. Bott, B. A. Richardson, J. Bwayo, J. Ndinya-Achola, and J. Overbaugh. 1999. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J. Virol. 73:4393-4403.
31. Nelson, N. C., M. A. Reynolds, and L. J. Arnold. 1995. Detection of acridinium esters by chemiluminescence, p. 391-428. In L. Kricka (ed.). Nonisotopic probing, blotting, and sequencing. Academic Press, San Diego, Calif.
32. Nolle, F. S., J. Boysza, C. Thurmond, W. S. Clark, and J. L. Lennox. 1998. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 36:716-720.
33. O'Brien, T. R., W. A. Blattner, D. Waters, E. Eyster, M. W. Hilgartner, A. R. Cohen, N. Luban, A. Hatzakis, L. M. Aledort, P. S. Rosenberg, W. J. Miley, B. L. Kroner, and J. J. Goedert. 1996. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 276:105-110.
34. O'Brien, W. A., P. M. Hartigan, D. Martin, J. Esinhart, A. Hill, S. Benoit, M. Rubin, M. S. Simherkoff, J. D. Hamilton, and the Veterans Affairs Cooperative Study Group on AIDS. 1996. Changes in plasma HIV-1 RNA and CD4' lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 334:426-431.
35. Parekh, B., S. Phillips, T. C. Granade, J. Baggs, D. J. Hu, and R. Respess. 1999. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res. Hum. Retroviruses 15:133-142.
36. Peeters, M., A. Gueye, S. Mboup, F. Bibollet-Ruche, E. Ekaza, C. Mulanga, R. Ouedrago, R. Gandji, P. Mpele, G. Dibanga, B. Koumare, M. Saidou, E. Esu-Williams, J. P. Lombart, W. Badombena, N. Luo, M. Vanden-Haesevelde, and E. Delaporte. 1997. Geographical distribution of HIV-1 group O viruses in Africa. AIDS 11:493-498.
37. Poss, M., J. Gosink, E. Thomas, J. K. Kreiss, J. Ndinya-Achola, K. Mandaliya, J. Bwayo, and J. Overbaugh. 1997. Phylogenetic evaluation of Kenyan human immunodeficiency virus type 1 isolates. AIDS Res. Hum. Retroviruses 13:493-499.
38. Rida, W., P. Fast, R. Hoff, and T. Fleming. 1997. Intermediate-size trials for the evaluation of HIV vaccine candidates: a workshop summary. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16:145-203.
39. Simon, J. H., N. C. Gaddis, R. A. Fouchier, and M. H. Malim. 1998. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4:1397-1400.
40. Subbarao, S., and G. Schochetman. 1996. Genetic variability of HIV-1. AIDS. 10:S13-S23.
41. Vandamme, A. M., S. Van Dooren, W. Kok, P. Goubau, K. Fransen, T. Kievits, J. C. Schmit, E. De Clercq, and J. Desmyter. 1995. Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCR. J. Virol. Methods 52:121-132.